Univest
Univest
  • Markets

Genesys Int Q1 FY27 Results: Revenue Rs 81 Cr, PAT Rs 5 Cr

  • August 17, 2026
  • Posted by: Kunal Singla
  • Category: Market
No Comments
Genesys Int Q1 FY27 Results: Revenue Rs 81 Cr, PAT Rs 5 Cr
 

Genesys Int Q1 FY27: Revenue Rs 81 Cr (+14% YoY). PAT Rs 5 Cr (-28% YoY). Gross Profit Rs 10 Cr. Consolidated. CMP Rs 175.00 on Aug 14, 2026.

Quick Answer

Genesys Int Q1 FY27 results showed consolidated revenue of Rs 81 crore (+14% YoY) with pat of Rs 5 crore (-28% YoY) and gross profit of Rs 10 crore. Results announced on August 14, 2026.

Genesys Int Q1 FY27 results showed consolidated revenue at Rs 81 crore, compared to Rs 71 crore in Q1 FY26 — a +14% change. The company operates across its core business segments and reported these Q1 FY27 results on August 14, 2026.

The Genesys Int Q1 FY27 results showed gross profit of Rs 10 crore (-28% YoY) versus Rs 14 crore in Q1 FY26. The pat of Rs 5 crore (-28% YoY) versus Rs 7 crore reflects the overall operating and financial outcome for the quarter.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Genesys Int Q1 FY27 Financial Highlights
  • Genesys Int Q1 FY27 Performance Analysis
  • Key Business Factors in Q1 FY27
    • Revenue Performance
    • Margin and Cost Dynamics
    • PAT Outcome
  • Dividend Details
  • FY27 Outlook
  • Genesys Int Stock Performance
  • Key Risks
    • Revenue Growth Sustainability
    • Margin Management
    • Macro and Sector Risks
  • Conclusion
  • Frequently Asked Questions on Genesys Int Q1 FY27 Results
    • When were Genesys Int Q1 FY27 results announced?
    • What was Genesys Int’s revenue in Q1 FY27?
    • What was Genesys Int’s pat in Q1 FY27?
    • What drove Genesys Int’s Q1 FY27 performance?
    • Did Genesys Int declare a dividend for Q1 FY27?
    • What is the outlook for Genesys Int after Q1 FY27 results?
    • Is Genesys Int a good investment after Q1 FY27 results?

Genesys Int Q1 FY27 Financial Highlights

Metric Q1 FY27 (Rs Crore) Q1 FY26 (Rs Crore) YoY Change
Revenue 81 71 +14%
Gross Profit 10 14 -28%
PAT / PAT 5 7 -28%

Genesys Int Q1 FY27 Performance Analysis

Use the Univest Screener to track Genesys Int live financials and Q1 FY27 results

Genesys Int Q1 FY27 results showed revenue of Rs 81 crore (+14% YoY), reflecting the prevailing market conditions and the company’s operational execution across its primary business segments.

Gross Profit at Rs 10 crore (-28% YoY) in Genesys Int Q1 FY27 results captures the direct cost economics — input costs, manufacturing or service delivery expenses — relative to the revenue generated in Q1 FY27.

The pat of Rs 5 crore (-28% YoY) in Genesys Int Q1 FY27 results represents the bottom-line outcome after accounting for all operating expenses, other income, and below-gross-profit costs.

Investors should evaluate Genesys Int Q1 FY27 results in the context of industry growth rates, the company’s competitive position, cost structure, and management’s FY27 guidance to form a comprehensive investment view.

Key Business Factors in Q1 FY27

Revenue Performance

Genesys Int Q1 FY27 results show revenue of Rs 81 crore (+14% YoY). Revenue trend reflects sector demand dynamics, competitive intensity, and the company’s market positioning in Q1 FY27.

Margin and Cost Dynamics

Gross Profit of Rs 10 crore (-28% YoY) in Genesys Int Q1 FY27 results reflects input cost trends, pricing power, and operational efficiency in the quarter.

PAT Outcome

The pat of Rs 5 crore (-28% YoY) captures the overall financial performance including both operational results and non-operating income or charges in Q1 FY27 results.

Dividend Details

Genesys Int has not declared a dividend for Q1 FY27. Annual dividend consideration will depend on full-year FY27 performance.

FY27 Outlook

The FY27 outlook for Genesys Int will be shaped by the revenue and margin trajectory visible from Q1 FY27 results. Key factors include sector demand trends, input cost management, competitive dynamics, and management’s execution capability.

Investors should monitor Q2 FY27 results for confirmation of the trends observed in Genesys Int Q1 FY27 results, particularly regarding revenue growth sustainability and margin progression.

Genesys Int Stock Performance

Download the Univest iOS App or Univest Android App to track Genesys Int share price live and stay updated on quarterly results.

Genesys Int shares traded at Rs 175.00 on August 14, 2026. The stock’s movement reflects the market’s immediate assessment of Q1 FY27 results in the context of prevailing sector valuations and growth expectations.

Key Risks

Revenue Growth Sustainability

Maintaining or improving the revenue trajectory from Genesys Int Q1 FY27 results depends on sector demand, competitive dynamics, and successful business development initiatives.

Margin Management

Gross and net margin sustainability in Genesys Int Q1 FY27 results and subsequent quarters is subject to input cost trends, pricing competition, and operational efficiency.

Macro and Sector Risks

Broader macroeconomic conditions, interest rate trends, and sector-specific regulatory changes could impact Genesys Int’s earnings trajectory from Q1 FY27 results.

Conclusion

Genesys Int Q1 FY27 results show revenue of Rs 81 crore (+14% YoY) and pat of Rs 5 crore (-28% YoY) — reflecting the company’s operating performance for April to June 2026.

Investors should conduct detailed sector and company-specific analysis, assess management strategy and guidance, before making investment decisions. Consult a SEBI-registered financial advisor.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on Genesys Int Q1 FY27 Results

When were Genesys Int Q1 FY27 results announced?

Ans. Genesys Int Q1 FY27 results were announced on August 14, 2026, covering the April to June 2026 quarter on a consolidated basis.

What was Genesys Int’s revenue in Q1 FY27?

Ans. Genesys Int reported consolidated revenue of Rs 81 crore in Q1 FY27, +14% from Rs 71 crore in Q1 FY26.

What was Genesys Int’s pat in Q1 FY27?

Ans. Genesys Int’s pat was Rs 5 crore in Q1 FY27, -28% from Rs 7 crore in Q1 FY26.

What drove Genesys Int’s Q1 FY27 performance?

Ans. Genesys Int Q1 FY27 results reflect the company’s sector positioning, operational execution, cost management, and prevailing market conditions in April-June 2026.

Did Genesys Int declare a dividend for Q1 FY27?

Ans. No dividend has been declared for Q1 FY27. Annual dividend prospects will depend on full-year FY27 earnings performance.

What is the outlook for Genesys Int after Q1 FY27 results?

Ans. The FY27 outlook depends on revenue and margin sustainability from Q1 FY27 results, sector demand trends, and management guidance for the rest of FY27.

Is Genesys Int a good investment after Q1 FY27 results?

Ans. Genesys Int Q1 FY27 results provide the latest financial update. Investors should assess sector positioning, valuation, and growth prospects before investing. Consult a SEBI-registered advisor.



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply